Press Release

Montreal, May 8, 2013—On the occasion of Mental Health Week, Univalor and 360Medlink have announced a new collaboration to develop and commercialize Persistance, a support program that encourages people with depression and generalized anxiety disorder to adhere to treatment and optimal medication plans. The Persistance program was designed by Dr. Yola Moride, a professor in the Faculty of Pharmacy of the Université de Montreal and a researcher at the Université de Montreal Hospital Research Centre (CRCHUM). It is part of the portfolio of inventions arising from university research that Univalor is working to commercialize.


We congratulate imarklab, a spin-off from HEC Montreal supported by Univalor, to have accompanied La Presse in the development of its new application La Presse+.  See how they did it! (french only)


On March 21, Univalor held the first Midi Transfert d’Univalor, in collaboration with Polytechnique Montréal. More than 75 students and researchers from the polytechnic attended the event, aimed at demystifying the steps to developing technology through academic research and transferring it to the marketplace.

Left to right: Christophe Guy (Director of Polytechnique Montreal), Mattias Shamlo (Director, Technology - Netclean), Daniel Jabler (Project Manager - Netclean) and Björn Samvik (Software Developer - Netclean), Jean-Pierre David (Professor at Polytechnique Montreal) and Anne-Marie Bourret ( Technology transfer Advisor at Polytechnique Montreal) Martinuzzo Thomas (Director, Business Development - Univalor) and Jacques Simoneau (President and CEO - Univalor)


Univalor congratulates the researchers from the University of Montreal (UdeM) who distinguished themselves in the most recent genomics and personalized health contest sponsored by Genome Canada and Genome Quebec. Five of the 17 Canadian projects came from UdeMresearchers, and two others had UdeM researchers as partners. This success is an outstanding example of the strength and vitality that drive UdeM’s researchers and its affiliated hospitals.


In the health field, cancer is now considered public enemy number one. In 2008, the World Health Organization (WHO) estimated that cancer caused 7.6 million deaths worldwide. On its own, cancer was responsible for about 13% of deaths on the planet. In Canada, the picture is even bleaker: since 2007, cancer has been the leading cause of death. During Daffodil Month, run by the Canadian Cancer Society, we offer you a glimpse into cancer research and emerging technologies.  As large and small victories accumulate, hopes of winning the war against the disease rise.